Medica Keeltabletten Aardbei

Chlorhexidine Dihydrochloride and Lidocaine Hydrochloride, the active ingredients in Medica Keeltabletten Aardbei, are an antiseptic and a local anesthetic presented as lozenges for oromucosal use. They help relieve oral mucosal infections, sore throat and mouth ulcer pain in patients of all ages.

GNH USA supplies Medica Keeltabletten Aardbei as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medica Keeltabletten Aardbei combines an antiseptic and a local anaesthetic to manage conditions of the oral mucosa.

- Oral mucosal infections: reduces microbial load and eases discomfort. - Sore throat: provides symptomatic relief together with antimicrobial action. - Mouth ulcer pain: numbs the area and helps prevent secondary infection.

Adverse reactions may occur with any oral antiseptic or local anaesthetic.

Common Side Effects: - Altered taste sensation. - Mild oral irritation or burning. - Transient numbness of the tongue or palate. - Nausea or mild stomach upset. - Headache. - Dysgeusia (metallic taste).

Serious or Rare Side Effects: - Allergic reactions such as angioedema or anaphylaxis. - Severe mucosal ulceration or necrosis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic lidocaine toxicity (e.g., seizures, cardiac arrhythmia) in case of overdose.

Use Medica Keeltabletten Aardbei only as directed by a healthcare professional.

- Hypersensitivity: avoid if known allergy to chlorhexidine or lidocaine. - Cardiac conditions: use with caution in patients with conduction disorders. - Frequency: do not exceed the prescribed number of lozenges per day. - Age restrictions: not recommended for children under 6 years unless advised by a clinician. - Pregnancy and lactation: consult a healthcare provider before use. - Store below 25°C: keep in the original pack, protect from moisture.

Potential drug interactions should be reviewed before initiating therapy.

Major Interactions (Avoid): - Concurrent systemic lidocaine (IV/IV infusion) may increase risk of toxicity. - Use with other chlorhexidine‑containing oral products may heighten mucosal irritation.

Moderate Interactions (Monitor Closely): - Antihistamines may mask early signs of an allergic reaction. - Beta‑blockers can affect lidocaine metabolism, requiring monitoring. - CYP450 inhibitors (e.g., erythromycin) may modestly increase lidocaine plasma levels.